Pinz Capital Management, LP Prelude Therapeutics Inc Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$6.9 - $13.22 $302,220 - $579,036
-43,800 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$11.89 - $31.74 $520,782 - $1.39 Million
43,800 New
43,800 $545,000
Q4 2020

Feb 16, 2021
SELL
$28.81 - $88.94 $896,019 - $2.77 Million
-31,101 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$26.2 - $30.13 $814,846 - $937,073
31,101 New
31,101 $937,000

Others Institutions Holding PRLD

# of Institutions
71
Shares Held
35.7M
Call Options Held
500
Put Options Held
300
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $47.3M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email